×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Cell: APOE4 Homozygous Astrocytes
cell
971 words
KG: ent-dise-1d66a04d
2026-03-25
kind:cell-type
section:cell-types
topic:alzheimers
state:published
Contents
APOE4 Homozygous Astrocytes
🧫
Cell Type Info
Cell Type
APOE4 Homozygous Astrocytes
Knowledge Graph
Related Hypotheses (27)
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
APOE Isoform Conversion Therapy
Score: 0.44
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
Microbial Inflammasome Priming Prevention
Score: 0.58
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Membrane Cholesterol Gradient Modulators
Score: 0.52
APOE4-Specific Microglial Metabolic Rescue
Score: 0.50
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Senescent Cell Mitochondrial DNA Release
Score: 0.54
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.48
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.41
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.38
Pharmacological Enhancement of APOE4 Glycosylation
Score: 0.37
Show 22 more
Related Analyses (30)
APOE4-driven lipid metabolism dysregulation in astrocytes an
neuroscience · failed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
Neuroinflammation and microglial priming in early AD
neurodegeneration · completed
Do APOE4-driven senescent astrocytes cause neurodegeneration
neurodegeneration · failed
How does APOE4 mechanistically increase TDP-43 pathology fre
neurodegeneration · failed
Which specific metabolic pathways in APOE4+ microglia are mo
neurodegeneration · completed
Mechanistic validation of SEA-AD differential expression hyp
neurodegeneration · failed
Do these mechanistic hypotheses explain layer-specific synap
neurodegeneration · failed
Do these mechanistic hypotheses from the SEA-AD Atlas bundle
neurodegeneration · failed
Which specific metabolic pathways in APOE4 microglia are cau
neurodegeneration · failed
Does structural 'normalization' of APOE4 domain interactions
neurodegeneration · failed
What is the high-resolution structure of the APOE4 hinge reg
structural biology · failed
How does APOE4's beneficial immune function reconcile with i
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Show 25 more
Related Experiments (25)
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.40
ApoE4 Function in Alzheimer's Disease
validation · proposed · Score: 0.40
Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40
Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.40
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.40
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Sleep and Circadian Dysfunction as Driver of Neurodegenerati
clinical · proposed · Score: 0.40
Sleep Disruption and Alzheimer's Disease — mechanism and int
clinical · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Viral Infections and Alzheimer's Disease — causal mechanisms
clinical · proposed · Score: 0.40
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40
Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.40
Show 20 more
See Also (15)
APOE4 (Apolipoprotein E4)
disease · Pages share 8 hypotheses
APOE3 (Apolipoprotein E3)
disease · Pages share 8 hypotheses
APOE2 (Apolipoprotein E2)
disease · Pages share 8 hypotheses
UPenn Observational Research Repository (NCT04715399)
clinical · Pages share 8 hypotheses
remternetug-anti-amyloid-alzheimers
clinical_trial · Pages share 8 hypotheses
ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 8 hypotheses
nct05508789
clinical_trial · Pages share 8 hypotheses
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 8 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 8 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 7 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 7 hypotheses
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 7 hypotheses
Endosomal Sorting Defects in Neurodegeneration
mechanism · Pages share 7 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Show 10 more